Prevas nomination committee has nominated Robert Demark, president of DeVenture AB, and Christer Wallberg, former president and CEO of Tacton Systems AB, as new members of the Prevas AB board of directors.
Picture: Robert Demark and Christer Wallberg
Robert Demark (born 1973) has more than 20 years of experience from board work and operational roles in small and medium-sized companies. Among other positions, Robert Demark served as a board member between 2017–2021 in the operating subsidiaries of the Evotech Group, which as of January 4, 2021 was acquired by Prevas. In addition to being responsible for the continuity of Evotech, Robert Demark will contribute with his solid experience in IT/technology consulting firms. In addition to being president of the family-owned investment company DeVenture AB, Robert Demark currently holds a number of board assignments. Robert Demark's holdings, as a representative of DeVenture AB, amount to 1,242,373 Series B shares.
Christer Wallberg (born 1959) has extensive experience in developing and leading rapidly growing companies. Christer Wallberg's career began in the biotechnology industry at Pharmacia Biotech, which is now Cytiva and a global leader in life sciences. Between 2001 and 2016, Christer Wallberg was president and CEO of Tacton Systems. Under his leadership, Tacton Systems grew from 19 employees into a world-leading global supplier in sales configuration and design automation with 200 employees. Before Tacton, Christer Wallberg had successfully built up companies such as E-Traveli and Pricer. Christer Wallberg has a master's degree in engineering from the Royal Institute of Technology and an MBA in Mergers & Acquisitions from Uppsala University. Christer Wallberg is currently a board member of six companies, with the primary focus in the manufacturing industry.
Robert Demark is independent in relation to the company and company management. Christer Wallberg is independent in relation to the company, company management and major shareholders.
Shareholders can vote on the nomination committee's nominations at Prevas AB's annual general meeting, which will be held on May 11, 2021 in Västerås, Sweden. More information about Prevas' annual general meeting is available at www.prevas.se/arsstamma.
For more information, contact
Nomination committee, arsstamma@prevas.se or
Johan Strid, President & CEO, Prevas AB, Cell: +46 703 79 10 61, E-mail
Archive news
2024-07-19 Prevas publishes the interim report for the second quarter of 2024
2024-07-11 Invitation to presentation of Prevas interim report January – June 2024
2024-06-19 Prevas receives regulatory approval for the acquisition of the Finnish company Enmac
2024-06-11 Exercise of warrants in Prevas’ warrant program 2021/2024